期刊文献+

抗精神病药物对精神疾病患者糖代谢影响的临床分析 被引量:5

Clinical Analysis of the Effect of Antipsychotic on Glycometabolism in the Patients with Mental Disorders
下载PDF
导出
摘要 目的:研究抗精神病药物对糖代谢的影响,以期为临床用药提供参考。方法:根据入组条件选定465例研究对象,测定其血糖,并用统计方法处理。结果:精神病人糖尿病发生率为3 68%,糖代谢异常发生率为9 89%,第1代抗精神病药糖代谢异常发生率高于第2代抗精神病药物。结论:抗精神病药物对糖代谢均有所影响,临床应用中应尽可能用糖代谢异常较小的药物,做到合理用药,以减少不良反应。 OBJECTIVE:To study the effect of antipsychotic on glycometabolism, in order to provide some references for clinical drug use. METHODS: 465 patie nts were selected for studying. Their blood sugar was determined, the results were dealt with by statistics. RESULTS: The incidence of diabetes in the patie nts with mental disorders was 3.68%, the incidence of abnormal glycometabolism was 9.89%. The incidence of abnormal glycometabolism induced by 1st generation antipsychotic was higher than that induced by the 2nd one. CONCLUSION: Since a ntipsychotic has some adverse effect on glycometabolism, so it is better to use drugs with less adverse effect on glycometabolism and use drugs rationally, in order to reduce adverse reactions.
作者 张程赪
出处 《中国医院用药评价与分析》 2005年第2期97-100,共4页 Evaluation and Analysis of Drug-use in Hospitals of China
  • 相关文献

参考文献8

二级参考文献29

  • 1李光伟,Step.,L.检测人群胰岛素敏感性的一项新指数[J].中华内科杂志,1993,32(10):656-660. 被引量:2125
  • 2[1]Henderson DC, Cagliero E, Gray C, et al. Clozapine, diabetes mellitus, weight gain and lipid abnormalities: a five-year naturalistic study. Am J Psychiatry, 2000, 157(6) : 975 ~981
  • 3[2]Ghaeli D, Dufresne RL. Elevated serum triglycerides with clozapine resolved with risperidone in four patients. Pharmacotherapy, 1999,19(9) : 1099~1101
  • 4[3]Leadbetter R , Shutty M , Pavalonis D , et al . Clozapine - induced weight gain: prevalence and clinical relevance. Am J Pchiatry,1992, 149 : 68 ~72
  • 5[4]Melksson K, Hulting AL. Antipsychotic drugs can affect hormone balance. Weight gain, blood lipid disturbances and diabetes are important. Lakartininger, 2001,98(48) : 5462 ~5464
  • 6[5]Haffner SM, Miettinen H, Stern MP. The homeostasis model in the San Antonio Heart Study. Diabetes Care, 1997, 20: 1087 ~ 1092
  • 7[7]Matthews DR, Hosker JP, Rudenski AS, et al. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia, 1985,28 : 412 ~419
  • 8[9]Wang PS, Glynn RJ, Ganz DA, et al. Clozapine use and risk of diabetes mellitus. J Clin Psychopharmacol, 2002, 22 (3) : 236 ~ 243
  • 9[12]Sowell MO, Makhopadkyay N, Cavazzoni P, et al. Hyperglycemic clamp assessment of insulin secretory responses in normal subjects treated with olanzapine, risperidone or placebo. J Clin Endocrinol Metab, 2002, 87(6) : 2918 ~2923
  • 10[13]Baptista T, Lacruz A, Angeles F, et al. Endocrine and metabolic abnormalities involved in obesity associated with typical antipsychotic drug administration. Pharmacopsychiatry, 2001,34(6) : 223 ~ 231

共引文献80

同被引文献33

引证文献5

二级引证文献34

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部